Chaga Mushroom (non-GMO) is prized by natural health practitioners who consider it far superior to anything else in nature. The Chaga Mushroom has been appreciated for thousands of years, dating as far back as the 16th century traditionally used in Eastern European folk medicine as a possible natural remedy for a wide selection of conditions. Worldwide it is considered 'The Medicinal King of Herbs' and a precious gift from nature. Chaga Mushroom draws its nutrients out of living birch trees, rather than from the ground. The amazing properties of betulin or betulinic acid, a chemical isolated from birch trees, is now being studied for use as a chemotherapy agent. Chaga contains large amounts of betulinic acid in a form that can be ingested orally, as well as the full spectrum of immune-stimulating phytochemicals found in other medicinal mushrooms such as maitake mushroom and shiitake mushroom.
For centuries Traditional Chinese Medicine practitioners have used Chaga Mushroom for general health, longevity, beauty, and as a remedy for the most serious health conditions. In Asian culture, the Chaga Mushroom is referred to as the 'Mushroom of Immortality' used to support immunity, supporting the body's ability to eliminate toxins while also supporting the nervous system. Raw Chaga Mushroom is a wonderful source of Melanin supporting youthful looks and vibrant skin. The Chaga Mushroom is known for its wonderful antioxidant properties and supporting a healthy inflammation response.
Today, the Chaga Mushroom is commonly used to support general health. Chaga Mushroom contains large amounts of phytonutrients and immune supporting compounds such as Beta Glycans and polysaccharides which may support the body's ability to set up cellular defenses. It has even been said that the Chaga Mushroom can balance metabolism and one's chi or vital energy levels.
The Chaga Mushroom is native to Western Siberia, Canada and USA and typically grows on the trunks of birch trees. Unlike other mushrooms with gills or caps, the Chaga has pores and is irregularly formed looking much like a burnt piece of charcoal. The Chaga is a parasitic mushroom that feeds on the white part of birch tree bark where the immune supporting substances are formed. This white part of the birch bark is also where the Chaga Mushroom obtains the powerful betulinic acid which may support the bodies fight of abnormal and uncontrolled cell division.
Raw Chaga Mushroom is 100% natural and harvested in the wild. It contain over 215 phytonutrients, has 25 to 50 times more SOD antioxidants than Agaricus, CoQ 10, vitamin C and wild blueberries, and is rated among the highest on the ORAC.
Some possible traditional uses of Raw Wildcrafted Chaga Mushroom Powder may include:
● High in immune supporting phytochemicals
● Supporting a healthy inflammatory response
● Incredibly high amounts of beta glucans, saponins, amino acids, betulinic acid, & natural minerals
● May support healthy Sleep
● May Protect against oxidation
● Supports the Detoxification process of the body
● May support healthy blood pressure
● Anti-viral properties
● Abundance of B Vitamins
● Natural source of Melanin supporting youthful looks & vibrant skin
● May reduce fatigue
● May support healthy mental function
● May support healthy digestion
● May Improve metabolism including activation of metabolism in cerebral tissue
● Supports a healthy cardiovascular & respiratory systems
● Supporting healthy blood glucose levels
● Reduction of gout
● Powerful anti-aging properties
● Excellent source of the enzyme SOD (Superoxide dismutase)
● Supports the central nervous & neurohumoral (they increase the activity of estrogens) systems of organism
This long kept secret of Eastern Europe is now available to you. Try it today!
Suggested Use: Steep 1 teaspoon in 6 ounces of boiling water for 10 minutes or mix 1 teaspoon with juice, yogurt or add to your favorite smoothie. Take 1 teaspoon up to 3 times daily.
Botanical Name: Inonotus Obliquus
Other Names: Birch mushroom, Black Birch Touchwood, Cinder conk, Mushroom of Immortality, Clinker polypore, Crooked Schiller-porling
Ingredients: Chaga Mushroom Powder.
Origin: Canada - Wildcrafted
Z Natural Foods strives to offer the highest quality organically grown, raw, vegan, gluten free, non-GMO products available and exclusively uses low temperature drying techniques to preserve all the vital enzymes and nutrients. Our raw Chaga Mushroom powder is wildcrafted and passes our strict quality assurance which includes testing for botanical identity, heavy metals, chemicals and microbiological contaminants. ZNaturalFoods.com offers raw Wild Chaga Mushroom powder packaged in airtight stand-up, resealable foil pouches for optimum freshness. Once opened, just push the air out of the pouch before resealing it in order to preserve maximum potency. Keep your Wild Chaga Mushroom powder in a cool, dark, dry place.
1. "Inonotus obliquus (Ach. ex Pers.) Pilát 1942". MycoBank. International Mycological Association. Retrieved 2011-10-11.
2. Needham, Arthur (2005-12-16). "Clinker Polypore, Chaga". Retrieved 10 October 2011.
3. Muma, Walter. "True Tinder Fungus". Retrieved 5 December 2012.
4. a b Müllauer, Franziska (2011). Betulinic Acid Induced Tumor Killing.
5. Yogeeswari, Perumal; Dharmarajan, Sriram (2005). "Betulinic Acid and Its Derivatives: A Review on their Biological Properties". Current Medicinal Chemistry (12): 657–666.
6. "Abstractverwaltung Congrex". Registration.akm.ch. Retrieved 2012-11-18.
7. Kathleen Blanchard (5 January 2011). "Betulin from birch bark could treat metabolic disorders". EmaxHealth.
8. a b Piaskowski S. - Preliminary studies on the preparation and application of preparations from black birch touchwood in human cases of malignant tumors. Sylwan 105: 5-11, 1957.
9. a b Zheng, W. F.; Liu, T.; Xiang, X. Y.; Gu, Q. (July 2007). "Sterol composition in field-grown and cultured mycelia of Inonotus obliquus". Yao xue xue bao = Acta pharmaceutica Sinica 42 (7): 750–756. PMID 17882960.
10. Zheng W, Miao K, Liu Y, Zhao Y, Zhang M, Pan S et al. (2010). "Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production.". Appl Microbiol Biotechnol 87 (4): 1237–54. doi:10.1007/s00253-010-2682-4. PMID 20532760.
11. Zheng, W. F. (July 2008). "Phenolic compounds from Inonotus obliquus and their immune-stimulating effects". Mycosystema 27 (4): 574–581.
12. a b Song, Y.; Hui, J.; Kou, W.; Xin, R.; Jia, F.; Wang, N.; Hu, F.; Zhang, H. et al. (2008). "Identification of Inonotus obliquus and Analysis of Antioxidation and Antitumor Activities of Polysaccharides". Current Microbiology 57 (5): 454–462. doi:10.1007/s00284-008-9233-6. PMID 18795365.
13. Tzianabos, Arthur O. (2000). "Polysaccharide Immunomodulators as Therapeutic Agents: Structural Aspects and Biologic Function". Clinical Microbiology Reviews 13 (4): 523–533. doi:10.1128/CMR.13.4.523-533.2000. PMC 88946. PMID 11023954.
14. Chung, Mi Ja; Chung, Cha-Kwon; Jeong, Yoonhwa; Ham, Seung-Shi (June 2010). "Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells". Nutrition Research and Practice 4 (3): 177–182. doi:10.4162/nrp.2010.4.3.177. PMC 2895696. PMID 20607061.
15. a b Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT (October 2005). "In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus". J Ethnopharmacol 101 (1-3): 120–8. doi:10.1016/j.jep.2005.04.003. PMID 15905055.
16. a b Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS (May 2006). "Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus". Life Sci. 79 (1): 72–80. doi:10.1016/j.lfs.2005.12.047. PMID 16458328.
17. Dosychev, E. A.; Bystrova, V. N. (May 1973). "Treatment of psoriasis using "Chaga" fungus preparations". Vestnik dermatologii i venerologii 47 (5): 79–83. PMID 4755970.
18. a b Paper with background on extraction processes
19. Rhee, S.Y. (2008). "A comparative study of analytical methods for alkali-soluble β-glucan in medicinal mushroom, Chaga (Inonotus obliquus)". LWT - Food Science and Technology 41 (3): 545–549.
20. Rzymowska J (January 1998). "The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities". Boll Chim Farm 137 (1): 13–5. PMID 9595828.
21. Cui Y, Kim DS, Park KC (January 2005). "Antioxidant effect of Inonotus obliquus". J Ethnopharmacol 96 (1-2): 79–85. doi:10.1016/j.jep.2004.08.037. PMID 15588653.
22. Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, Kim HM, Shin CS (September 2005). "Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus". Life Sci. 77 (19): 2438–56. doi:10.1016/j.lfs.2005.02.023. PMID 15970296.
23. Mizuno T. (1999). "Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus". International Journal of Medicinal Mushrooms 1 (1): 301–316.
24. Anonymous. 2004. Cytotoxic effect of Inonotus obliquus composition in
HCT-15 human colon and AGS gastric cancer cells. Journal of the
Korean Society of Food Science and Nutrition. 33:633-640.
25. Alves, R. E., et al. 2002. Camu camu (Myrciaria dubia Mc Vaugh): a
rich natural source of vitamin C. Proc. Interamer. Soc. Trop. Hort.
26. Ajith, T. A. and K. K. Janardhanan. 2007. Indian medicinal mushrooms
as a source of antioxidant and antitumor agents. J. Clin. Biochem. Nutr.
27. Babitskaya, V. G,, Scherba, V. V., Ikonnikova, N.V., Bisko, N.A., and
N.Y. Mitropoiskaya. 2002. Melanin complex from medicinal mushroom
Inonotus obliquus (Pers:Fr.) Pilat (Chaga) (Aphyllophoromycetidae).
Int. J. Med. Mushrooms. 4:139-45.
28. Bobek, P., Ozdin, L., and I. Kajaba. 1997. Dose-dependent
hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in
rats. Physiol Res. 47:327-329.
29. Bobek, P. and S. Galbavy. 1999. Hypocholesteremic and antiatherogenic
effect of oyster mushroom (Pleurotus osteratus) in rabbits. Nahrung.
30. Burczyk, J., Gawron, A. Slotwinska, M., Smietana, B., and K.
Terminiska. 1996. Antimitotic activity of aqueous extracts of Inonotus
obliquus. Boll. Chim. Farm. 135:306.
31. Chang, S. T. 1999. Global impact edible and medicinal mushrooms on
human welfare in the 21st century: non-green evolution. Int. J. Med.
32. Chen, C., Zheng, W., Gao, X., Xiang, X., Sun, D., Wei, J., and C. Chu.
2007. Aqueous extract of Inonotus obliquus (Fr.) pilat
(Hymenochaetaceae) significantly inhibits the growth of sarcoma 180 by
inducing apoptosis. American Journal of Pharmacology and Toxicology.
33. Chihara, G., Maeda, Y., Sasaki, T. and F. Fukuoaka. 1969. Inhibition of
mouse sarcoma 180 by polysaccharides from Letin us eodes (Berk.)
34. Chorvathova, V., et al. 1993. Effect of oyster fungus on glycemia and
cholesterolaemia in rats with insluin-dependent diabetes. Physiol. Res.
35.Cui, Yo, Kim, D. S., and K. C. Park. 2005. Antioxidant effects of
Inonotus Oblique. J. Ethnopharmacol. 96:79-85.
36. de Sa, M. S., et al. 2009. Antimalarial activity of betulinic acid and
derivatives in vitro against Plasmodium falciprum and in vivo in P.
Berghel-infected mice. Parisitol. Res. Jul;105:275-279.
37. Fulda, S, et al. 1997. Betulinic acid triggers CD95 (APO-1/Fas)- and
p53-independent apoptosis via activation of capases in neuroectodermal
tumors. Cancer Research. 57:4956.
38. Fulda, S. 2008. Betulinic acid for cancer treatment and prevention. Int.
J. Mol. Sci. 9:1096-1107.
39.Fulda, S., Jeremias, I., Pietsch, T. and K. M. Debatin. Betulinic acid: a
new chemotherapeutic agent in the treatment of neuroectodermal
tumors. Klin Padiatr. 211:319-322.
40.Gu, Y. and S. Gowsala. 2006. Cytotoxic effect of oyster mushroom
Pleurotus ostreatus on human androgen-independent prostate cancer
PC-3 cells. J. Med. Food. 9:196-204.
41. Ham, S. S., et al. 2003. Antimutagenic and cytotoxic effects of ethanol
extract from the Inonotus obliquus. J. Korean Soc. Food Sci. Nutr.
42. Hawksworth, D. L. 2001. Mushrooms: the extent of the unexplored
potential. Int. J. Med. Mushr. 2:1-9.
43.Hossain, S., et al. 2003. Dietary mushroom (Pleurotus ostreatus)
ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin. Exp.
Pharmacol. Physiol. 30:470-475.
44. Hyun, K. W., Jeong, S. C., Lee, D. H., Park, J. S., and J. S. Lee. 1996.
Isolation and characterization of a novel platelet aggregation inhibitory
peptide from the medicinal mushroom, Inonotus obliquus. Boll. Chim.
45.In-Kyoung, L., Young-Sook, K., Yoon-Woo, J., Jin-Young, J., and Y.
Bong-Suk. 2007. New antioxidant polyphenols from the medicinal
mushroom Inonotus obliquus. Bioorganic & Medicinal Chemistry
46.Jeremias, I., et al. 2004. Cell death induction by betulinic acid, ceramide,
and TRAIL in primary glioblastoma multiforme cells. Acta
47.Kahlos, K., Kangas, L., and R. Hiltunen. 1987. Antitumor activity of
some compounds and fractions from an n-hexane extract of Inonotus
obliquus in vitro. Acta Pharm. Fennica. 96:33-40.
48.Kharazmi, A. 2008. Laboratory and preclinical studies on the antiinflammatory
and anti-oxidant properties of rosehip powder—
identification and characterization of the active component GOPO.
Osteoarhritis and Cartilage. 16:55-57.
49. Kim, B. K., Shin, G.G., Jeong, B.S., and J.Y. Cha. 2001. Cholesterol
lowering effect of mushrooms powder in hyperlipidemic rats. J. Korean
Soc. Food Sci. Nutr. 30:510-515.
50.Kim, Y. O., et al. 2005. Immuno-stimulatory effect of the
endopolysaccharide produced by submerged culture of Inonotus
obliquus. Life Sci. 77:2438-56.
51.Kim,Y. O., et al. 2006.Anti-cancer effect and structural characterization
of endo-polysaccharide from cultivated mycelia of Inonotus obliquus.
Life Sci. 79:72-80.
52.Koyama, T., Yeunhwa, G., and T. Akira. 2008. Fungal medicine,
Fuscoporia obliqua, as a traditional herbal medicine, in vivo testing and
medicinal effects. Asian Biomedicine. 2:459-469.
53.Kraus-Zaki, J. 1957. (In Polish) ACTH jako czynnuk hydrolizujacy
kwasy dezoksyrybonukleinowe w zastosowaniu do bada
cytoenzymatycznych. Haematologica. 1:48-50.
54.Krauss-Zaki, J. 1962. Correspondence: Digestion of Cell Nucleus by
Enzymes. Blood Journal. 19:527.
55.Lindequist, U., Niedermeyer, T. H. J., and W-D Julich. 2005. The
pharmacological potential of mushrooms. Institute of Pharmacy,
56. Lull, C., Wichers, H. J., and H. F. J. Savelkoul. 2005. Antiinflammatory
and immunomodulating properties of fungal metabolites (In) Mediators
of Inflammation. Hindawi Publishing Corp.
57. McCord, J. M. and I. Fridovich. 1988. Superoxide dismutase: the first
twenty years (1968-1988). Free Radic. Biol. Med. 5(5-6):363-369.
58. Mizuno, T., et al. 1999. Antitumor and hypoglycemic activities of
polysaccharides from Sclerotia and mycelia of Inonotus obliquus. Int. J.
Med. Mushrooms. 1:306.
59. Mizuno, T. 1999. The extraction and development of antitumor-active
polysaccharides from medicinal mushrooms in Japan (review). Int. J.
Med. Mushr. 1:9-30.
60.Mothana, R. A. A., Awadh, N. A. A., Jansen, R.,Wegner, U., Mentel, R.,
and U. Lindequist. 2003. Antiviral lanostanoid triterpenes from the
fungus Ganoderma pfeifferi BRES Fitoteraia. 74:483-485.
61. Mullauer, F. B., Kessler, J. H., and J. P.Medema. Betulin is a potent antitumor
agent that is enhanced by cholesterol. 2009. (by) Laboratory for
Experimental Oncology and Radiology, PLoS One; 4(4).
62. Muller, F. L., et al. 2006. Absence of CuZn superoxide dismutase leads
to elevated oxidative stress and acceleration of age-dependent skeletal
muscle atrophy. Free Radic. Biol. Med. 40:1993-2004.
63. Najafzadeh, M., et al. 2007. Chaga mushroom extract inhibits oxidative
DNA damage in lymphocytes of patients. Biofactors. 31:191-200.
64. Nakagawa-Goto, K., Taniguchi, M., Tokuda, H., and K. H. Lee. 2008.
Cancer preventive agents 9. Betulinic acid derivatives as potent cancer
chemopreventive agents. Bioorg. Med. Chem. Lett. 1;19:3378-3381.
65. Nasar-Abbas, S. M. and A. Kadir Haikman. 2004. Antimicrobial effect
of water extract of sumac (Rhus coriaria L.) on the growth of some food
borne bacteria, including pathogens. J. Food Micro. 10:1016.
66. Nicolson, G. L., et al. 2000. Diagnosis and integrative treatment of
intercelluar bacterial infections in chronic fatigue and fibromyalgia
syndromes, GulfWar Illness, and rheumatoid arthritis and other chronic
illnesses. Clin. Prac. Alt. Med. 1:92.
67. Nicolson, G. L. 2002. Co-infections in fibromyalgia syndrome, chronic
fatigue syndrome, and other chronic illnesses. National Fibromyalgia
Partnership—Fibromyalgia Frontiers. 10:5-9; 27-28.
68. Papas, A. M. (ed). 1999. Anitoxidant Status, Diet, Nutrition, and Health.
Boca Raton: CRC Press.
Park,Y. M., et al. 2005. In vivo and in vitro anti-inflammatory and antinociceptive
effects of the methanol extract of Inonotus obliquus. J.
69.Park,Y. M., et al. 2007. In vivo and in vitro anti-inflammatory and antinociceptive
effects of the methanol extract of Inonotus obliquus. J. Med.
70. Rein, E., Kharazmi, A., and K. Winther. 2004. A herbal remedy, Hyben
Vital (stand. Powder of Rosa canina fruits) reduces pain and improves
general welbeing in patients with osteoarthritis- a double-blind, placebo
controlled randomized trial. Phytomedicine. 11:383.
71. Rzymowska, J. 1996. The effect of aqueous extracts from Inonotus
obliquus on the mitotic index and enzyme activities. Boll Chim. Farm.
72.Sarkar, F. H. andY. Li. 2006. Using chemoprevention agents to enhance
the efficacy of cancer therapy. Cancer Res. 66:3347.
73. Sawada, N., et al. 2004. Betulinic acid augments the inhibitory effects of
vincristine on growth and lung metastasis of B16F10 melanoma cells in
mice. British Cancer Journal. 90:1672.
74.Scott, Cyril. 1944. Health, Diet, and Common Sense. London: the
Homeopathic Publishing Co.
75. Shin, Y., Tamai, Y., and M. Terazawa. 2000. Chemical constituents of
Inonotus obliquus sclerotium. Eurasian Journal of Forest Research.
76. Shivrina, A.N. 1967. Chemical characteristics of compounds extracted
from Inonotus obliquus. Chem. Abstr. 66:17271-17279.
77. Sudhakar, C., Sabitha, P., Shashi, K. R. and S. Safe. 2007. Betulinic acid
inhibits prostate cancer growth through inhibition of specificity protein
transcription factors. Cancer Research. 67:2816.
78. Sung, B., et al. 2008. Identification of a novel blocker of lkappaBalpha kinase
activation that enhances apoptosis and inhibits proliferation and invasion
by suppressing nuclear factor-kappaB. Mol. Cancer Ther. 7:19-201.
79. Takada, Y. and B. B. Aggarawal. 2003. Betulinic acid suppresses
carcinogen-induced NF-kB activation through inhibition of lkappaB
alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2
and matrix metalloprotease-9. Journal of Immunology. 171:3278.
80. Wang, H., Gao, J., and T. B. Ng. 2000. A new lectin with highly potent
antihepatoma and antisarcoma activities from the oyster mushroom
Pleurotus ostreatus. Biochem. Biophys. Res. Commun. 275:810-816.
81. Wick, W., Grimmel, C., Wagenknecht, B., Dichgans, J. and M. Weller.
1999. Betulinic acid-induced apoptosis in glioma cells: A sequential
requirement for new protein synthesis, formation of reaction oxygen
species, and caspase processing. J. Pharmacol. Exp. Ther. 289:1306-
82. Willmann, M. et al. 2009. Characterization of NVX-207, a novel
betulinic acid-derived anti-cancer compound. Eur. J. Clin. Invest.
83. Winther, K., Apel, K. and G. Thamsborg. 2005. A powder made from
seeds and shells of a rose-hip subspecies (Rosa canina) reduces
symptoms of knew and hip osteoarhritis: A randomized, double-blind
placebo controlled trial. Scand J. Rheumatol. 34:302.
84. Yesilada, E., et al. 1997. Inhibitory effects of Turkish folk remedies on
inflammatory cytokin: interleukin-1 alpha, interleukin-1 beta, and tumor
necrosis factor alpha. J. Ethnopharmacol. 58:59-73.
85. Ying-Mee, T., Yu, Rong, and J. M. Pezzuto. 2003. Betulinic acidinduced
programmed cell death in human melanoma cells involves
mitogen-activated protein kinase activation. Clinical Cancer Research.